Turning complex clinical data into confident decisions.

Clinical data, real-world evidence, and regulatory expertise for the moments that matter most.

Meet the woman behind the data.

The science is complex. The goal should be clear.

Dr. Dany is a principal statistical analyst and data science leader with deep experience in pharmaceutical and CRO statistical programming. She works alongside biometrics, clinical development and regulatory affairs teams, with a strong grasp of the regulatory requirements behind them, including GCP and ICH.
She implements CDISC standards so that NDA and BLA submissions stay accurate, traceable and compliant. She works in SAS and R, and she leads several projects and cross-functional teams at once.
Dr. Dany works where clinical data, technology, and regulatory expectations intersect helping organizations turn complex information into reliable, submission-ready deliverables.

What I do best

Five areas where complexity turns into clarity.

Clinical Data

Helping organizations structure, manage, and transform complex clinical datasets.

FDA Submissions

Supporting regulatory-ready and submission-ready deliverables for demanding life-sciences programs.

RWE

Turning real-world and observational data into useful, structured evidence.

Statistical Programming

SAS, R, Python, statistical programming, reporting, and modern data workflows.

CDISC

SDTM, ADaM, standards, specifications, and submission readiness.
Signature Approach

Where science meets strategy.

Step 1
Clinical Data
Step 2
Statistical Programming
Step 3
Standards
Step 4
Evidence
Step 5
Regulatory Submission
Step 6
Confident Decisions

20+ years of experience. One consistent focus: getting complex work right.

2012 to present

STATProg Inc.

Founder & President
Statistical programming and data analysis consulting for healthcare and clinical trial sponsors, from Phase II studies to regulatory submission packages.
2019 to 2025

Nestlé Health Science

Senior Statistical Programming & Regulatory Submission Managing Consultant
Led statistical programming for Phase II allergy and immunology studies, including full submission packages and the CRO and vendor teams behind them.
2025 to 2026

Bitterroot Pharma

Senior Consultant
Statistical programming for a Phase II pharmacokinetics and pharmacodynamics atherosclerosis study, with outputs for Data Review Committees and a SAS macro library for clinical data review.
Full portfolio

Want the full picture?

Dr. Dany’s complete CV covers every engagement, project and paper. To request a copy, please get in touch directly.

Complexity is not the problem. Clarity is the opportunity.

Let's talk about what you're building.

Whether the challenge is clinical data, regulatory readiness, real world evidence, statistical programming, or modernizing a complex data environment, Dr. Dany brings experience, precision, and perspective to the table.